If you made any changes in Pure these will be visible here soon.

Research Output 1988 2020

Filter
Article
Article

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma

Corso, A., Arcaini, L., Caberlon, S., Zappasodi, P., Mangiacavalli, S., Lorenzi, A., Rusconi, C., Troletti, D., Maiocchi, M. A., Pascutto, C., Morra, E. & Lazzarino, M., Oct 2002, In : Haematologica. 87, 10, p. 1041-1045 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Poisons
Etoposide
Multiple Myeloma
Cyclophosphamide

A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome

Bernasconi, P., Cavigliano, P. M., Genini, E., Castagnola, C., Malcovati, L., Calatroni, S., Caresana, M., Boni, M., Alessandrino, E. P., Astori, C., Corso, A. & Bernasconi, C., Sep 1998, In : Cancer Genetics and Cytogenetics. 105, 2, p. 182-186 5 p.

Research output: Contribution to journalArticle

Chromosome Deletion
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Chromosomes, Human, Pair 7
Chromosomes, Human, Pair 5
zoledronic acid
Osteonecrosis
Jaw
pamidronate
Multiple Myeloma

Advantages of using thalidomide for the management of patients with refractory myeloma

Corso, A., Lorenzi, A., Orlandi, E., Astori, C., Mangiacavalli, S. & Lazzarino, M., 2002, In : Haematologica. 87, 3, p. 327-328 2 p.

Research output: Contribution to journalArticle

Thalidomide
Outpatients
Clone Cells
Drug Therapy

An update of the APEX study

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 2-4 3 p.

Research output: Contribution to journalArticle

A protocol for the enrichment of different types of CFU-S from fetal mouse liver

Corso, A., Hogeweg-Platenburg, M. G. C., De Vries, P. & Visser, J. W. M., 1993, In : Haematologica. 78, 1, p. 5-11 7 p.

Research output: Contribution to journalArticle

Assessment of renal function in patients with multiple myeloma: The role of urinary proteins

Corso, A., Serricchio, G., Zappasodi, P., Klersy, C., Bosoni, T., Moratti, R., Castagnola, C., Lazzarino, M., Pagnucco, G. & Bernasconi, C., Aug 1999, In : Annals of Hematology. 78, 8, p. 371-375 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Creatinine
Kidney
Hexosaminidases
Serum

A striking response to bortezomib in a patient with pleural localization of multiple myeloma

Mangiacavalli, S., Varettoni, M., Zappasodi, P., Pica, G., Lazzarino, M. & Corso, A., Apr 2009, In : Leukemia Research. 33, 4, p. 577-578 2 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, G. A. & Morabito, F., Dec 6 2016, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Mar 1 2017, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Bahlis, N. J., Corso, A., Mugge, L. O., Shen, Z. X., Desjardins, P., Stoppa, A. M., Decaux, O., De Revel, T., Granell, M., Marit, G., Nahi, H., Demuynck, H., Huang, S. Y., Basu, S., Guthrie, T. H., Ervin-Haynes, A., Marek, J., Chen, G. & Facon, T., Nov 1 2017, In : Leukemia. 31, 11, p. 2435-2442 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Thalidomide
Therapeutics
Dexamethasone
Melphalan

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Harousseau, J. L., Dimopoulos, M. A., Wang, M., Corso, A., Chen, C., Attal, M., Spencer, A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., Knight, R. D. & Weber, D. M., Oct 2010, In : Haematologica. 95, 10, p. 1738-1744 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Survival
lenalidomide
Reaction Time

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

Corso, A., Arcaini, L., Mangiacavalli, S., Astori, C., Orlandi, E., Lorenzi, A., Passamonti, F., Klersy, C., Pascutto, C., Canevari-Sciorati, A. & Lazzarino, M., 2001, In : Haematologica. 86, 4, p. 394-398 5 p.

Research output: Contribution to journalArticle

Bone Diseases
Multiple Myeloma
Biomarkers
Monoclonal Gammopathy of Undetermined Significance
Osteocalcin

Blood stem cell collections in multiple myeloma: Definition of a scoring system

Corso, A., Caberlon, S., Pagnucco, G., Klersy, C., Zappasodi, P., Alessandrino, E. P., Vanelli, L., Mangiacavalli, S., Lazzarino, M. & Bernasconi, C., 2000, In : Bone Marrow Transplantation. 26, 3, p. 283-286 4 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Platelet Count
Blood Cells
Granulocyte-Macrophage Progenitor Cells

Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Klersy, C., Rusconi, C., Colucci, E., Lorenzi, A., Troletti, D., Consensi, E. & Lazzarino, M., Feb 2005, In : Leukemia Research. 29, 2, p. 159-163 5 p.

Research output: Contribution to journalArticle

Bone Marrow Cells
Stem Cells
Cell Count
Bone Marrow
Multiple Myeloma

Bone marrow T-cell subsets in patients with monoclonal gammopathies: Correlation with clinical stage and disease status

Corso, A., Castelli, G., Pagnucco, G., Lazzarino, M., Bellio, L., Klersy, C. & Bernasconi, C., Jan 1997, In : Haematologica. 82, 1, p. 43-46 4 p.

Research output: Contribution to journalArticle

Paraproteinemias
T-Lymphocyte Subsets
Multiple Myeloma
Bone Marrow Cells
Bone Marrow

Bortezomib: Introduction

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 1 1 p.

Research output: Contribution to journalArticle

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Montefusco, V., Corso, A., Galli, M., Ardoino, I., Pezzatti, S., Carniti, C., Patriarca, F., Gherlinzoni, F., Zambello, R., Sammassimo, S., Marcatti, M., Nozza, A., Crippa, C., Cafro, A. M., Baldini, L. & Corradini, P., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Dexamethasone
Recurrence
Disease-Free Survival
Peripheral Nervous System Diseases
Multiple Myeloma
Neuralgia
Incidence
Bortezomib

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma

Corso, A., Barbarano, L., Mangiacavalli, S., Spriano, M., Alessandrino, E. P., Cafro, A. M., Pascutto, C., Varettoni, M., Bernasconi, P., Grillo, G., Carella, A. M., Montalbetti, L., Lazzarino, M. & Morra, E., Feb 2010, In : Leukemia and Lymphoma. 51, 2, p. 236-242 7 p.

Research output: Contribution to journalArticle

Autografts
Dexamethasone
Stem Cells
Drug Therapy
Etoposide

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Algarotti, A., Pascutto, C. & Lazzarino, M., Nov 2009, In : European Journal of Haematology. 83, 5, p. 449-454 6 p.

Research output: Contribution to journalArticle

Dexamethasone
Peripheral Nervous System Diseases
Multiple Myeloma
Bortezomib
Therapeutics

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

Jurczyszyn, A., Grzasko, N., Gozzetti, A., Czepiel, J., Cerase, A., Hungria, V., Crusoe, E., Silva Dias, A. L. M., Vij, R., Fiala, M. A., Caers, J., Rasche, L., Nooka, A. K., Lonial, S., Vesole, D. H., Philip, S., Gangatharan, S., Druzd-Sitek, A., Walewski, J., Corso, A. & 31 others, Cocito, F., Vekemans, M. C. M., Atilla, E., Beksac, M., Leleu, X., Davila, J., Badros, A., Aneja, E., Abildgaard, N., Kastritis, E., Fantl, D., Schutz, N., Pika, T., Butrym, A., Olszewska-Szopa, M., Usnarska-Zubkiewicz, L., Usmani, S. Z., Nahi, H., Chim, C. S., Shustik, C., Madry, K., Lentzsch, S., Swiderska, A., Helbig, G., Guzicka-Kazimierczak, R., Lendvai, N., Waage, A., Andersen, K. T., Murakami, H., Zweegman, S. & Castillo, J. J., Jun 1 2016, In : American Journal of Hematology. 91, 6, p. 575-580 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Central Nervous System
Retrospective Studies
Survival
Radiotherapy

Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

Zappasodi, P., Corso, A., Klersy, C., Pica, G., Mangiacavalli, S., Varettoni, M., Rusconi, C., Pascutto, C. & Lazzarino, M., Feb 2006, In : European Journal of Cancer. 42, 3, p. 396-402 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Epidemiology
Therapeutics
Monoclonal Gammopathy of Undetermined Significance
Recurrence

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: A single-center experience with 1400 patients

Varettoni, M., Corso, A., Cocito, F., Mangiacavalli, S., Pascutto, C., Zappasodi, P., Pica, G. & Lazzarino, M., Jul 2010, In : Medicine (United States). 89, 4, p. 211-216 6 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Bone Marrow Cells
Immunoglobulin M
Albumins

Chronic myelogenous leukemia and exposure to ionizing radiation - a retrospective study of 443 patients

Corso, A., Lazzarino, M., Morra, E., Merante, S., Astori, C., Bernasconi, P., Boni, M. & Bernasconi, C., Feb 1995, In : Annals of Hematology. 70, 2, p. 79-82 4 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Ionizing Radiation
Retrospective Studies
Splenomegaly
Mutagens

Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia

Lazzarino, M., Regazzi, M. B. & Corso, A., 1996, In : Leukemia and Lymphoma. 23, 5-6, p. 539-543 5 p.

Research output: Contribution to journalArticle

Considerations in the treatment of multiple myeloma: A consensus statement from Italian experts

Patriarca, F., Petrucci, M. T., Bringhen, S., Baldini, L., Caravita, T., Corradini, P., Corso, A., Di Raimondo, F., Falcone, A., Ferrara, F., Morabito, F., Musto, P., Offidani, M., Petrini, M., Rizzi, R., Semenzato, G., Tosi, P., Vacca, A., Cavo, M., Boccadoro, M. & 1 others, Palumbo, A., Feb 2009, In : European Journal of Haematology. 82, 2, p. 93-105 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Thalidomide
Therapeutics
Transplants

Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: A single center experience

Castagnola, C., Alessandrino, E. P., Lunghi, M., Bernasconi, P., Della Porta, M., Mangiacavalli, S., Colombo, A., Corso, A., Pagnucco, G., Lazzarino, M. & Bernasconi, C., 2001, In : Annals of Hematology. 80, 5, p. 267-271 5 p.

Research output: Contribution to journalArticle

Cell Transplantation
Acute Myeloid Leukemia
Blood Cells
Stem Cells
Consolidation Chemotherapy

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jȩdrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., May 10 2012, In : New England Journal of Medicine. 366, 19, p. 1759-1769 11 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Prednisone
Therapeutics
Disease-Free Survival

Correction: Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: A cost-effectiveness analysis (PLoS ONE)

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Jan 8 2014, In : PLoS One. 9, 1

Research output: Contribution to journalArticle

DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma

Lazzarino, M., Corso, A., Barbarano, L., Alessandrino, E. P., Cairoli, R., Pinotti, G., Ucci, G., Uziel, L., Rodeghiero, F., Fava, S., Ferrari, D., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Morandi, S., Perego, D., Santagostino, A., Savarè, M. & 2 others, Vismara, A. & Morra, E., 2001, In : Bone Marrow Transplantation. 28, 9, p. 835-839 5 p.

Research output: Contribution to journalArticle

Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Cisplatin

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

Zappasodi, P., Nosari, A. M., Astori, C., Ciapanna, D., Bonfichi, M., Varettoni, M., Mangiacavalli, S., Morra, E., Lazzarino, M. & Corso, A., May 2008, In : Transfusion. 48, 5, p. 857-860 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Multiple Myeloma
Leukapheresis
Drug Therapy
Body Weight

DIAGNOSI DI LINFOMA NON-HODGKIN IN UN PAZIENTE AFFETTO DA SINDROME DI MARFAN

Translated title of the contribution: Diagnosis of lymphoma in a patient with Marfan syndromeCorso, A., Pagnucco, G., Morra, E. & Bernasconi, C., 1993, In : Minerva Medica. 84, 7-8, p. 417-419 3 p.

Research output: Contribution to journalArticle

Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma

Corso, A., Lorenzi, A., Zappasodi, P., Invernizzi, R., Vanelli, L. & Lazzarino, M., Aug 1 2003, In : Haematologica. 88, 8, p. 958-960 3 p.

Research output: Contribution to journalArticle

Thalidomide
Bone Marrow
Erythroblasts
Megakaryocytes
Multiple Myeloma

Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma

Corso, A., Mangiacavalli, S., Nosari, A., Castagnola, C., Zappasodi, P., Cafro, A. M., Astori, C., Bonfichi, M., Varettoni, M., Rusconi, C., Troletti, D., Pascutto, C., Morra, E. & Lazzarino, M., Dec 2005, In : Bone Marrow Transplantation. 36, 11, p. 951-954 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone

Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study

Oriol, A., Giraldo, P., Kotsianidis, I., Couturier, C., Olie, R., Angermund, R. & Corso, A., Aug 1 2015, In : Hematology. 20, 7, p. 405-409 5 p.

Research output: Contribution to journalArticle

Retreatment
Multiple Myeloma
Retrospective Studies
Safety
Recurrence

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Mangiacavalli, S., Pica, G., Varettoni, M., Lazzarino, M. & Corso, A., Mar 2009, In : European Journal of Haematology. 82, 3, p. 240-241 2 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 841-843 3 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 839-841 3 p.

Research output: Contribution to journalArticle

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnucco, G., Astori, C., Corso, A., Brusamolino, E., Simoncini, L., Morra, E. & Bernasconi, C., 1999, In : Annals of Oncology. 10, 1, p. 59-64 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
fludarabine phosphate
Agranulocytosis
fotemustine
Multiple Myeloma
Dexamethasone
Alkylating Agents
Disease-Free Survival

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program

Mikhael, J. R., Belch, A. R., Prince, H. M., Lucio, M. N., Maiolino, A., Corso, A., Petrucci, M. T., Musto, P., Komarnicki, M. & Stewart, A. K., Jan 2009, In : British Journal of Haematology. 144, 2, p. 169-175 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Peripheral Nervous System Diseases
Neutropenia
Thrombocytopenia